Tru Shrimp names Chitogen as first large-scale chitosan buyer
Plymouth, Minnesota, U.S.A.-based medical manufacturing company Chitogen Inc. has signed a letter of intent with Balaton, Minnesota-based Trū Shrimp to purchase commercial quantities of chitosan produced from the ground-up exoskeletons of its farm-raised shrimp.
Tru Shrimp President and CEO Michael Ziebell told SeafoodSource in October 2022 his company's entrance into the chitosan market represents an important growth avenue for the start-up, which operates a pilot facility in Minnesota and which is seeking to build a large-scale land-based shrimp farm in the U.S. state of South Dakota. In August 2022, Tru Shrimp announced it had commenced production of a branded line of premium chitosan for topical and internal medical, pharmaceutical, and cosmetic applications ...
Photo courtesy of Tru Shrimp